EVH · Evolent Health, Inc.
$4.68
+0.02 (+0.43%)
At close · Aug 14
Market Cap
$529.12M
Shares
113.06M
Evolent Health, Inc. Earnings Call Transcripts
Every quarterly earnings call for Evolent Health, Inc. (EVH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲58.5%
$352.58M
$2.12M
'22 Q3
22-11-02
▲54%
$382.43M
−$11.35M
'22 Q4
23-02-22
▲44%
$427.69M
−$19.98M
'23 Q1
23-05-03
▲46.6%
$469.14M
−$34.32M
'23 Q2
23-08-02
▲44.9%
$511.01M
−$25.32M
'23 Q3
23-11-02
▲45.4%
$556.05M
−$33.41M
'23 Q4
24-02-22
▲49.6%
$639.65M
−$17.28M
'24 Q1
24-05-09
▲37.9%
$647.14M
$1.60M
'24 Q2
24-08-08
▲21.6%
$621.40M
−$23.14M
'24 Q3
24-11-07
▲16.3%
$646.54M
−$22.80M
'24 Q4
25-02-20
▼24.4%
$483.65M
−$64.62M
'25 Q1
25-05-08
▼31.3%
$444.33M
−$19.90M
'25 Q2
25-08-07
▼22.8%
$479.53M
−$20.86M
'25 Q3
25-11-06
▼27.5%
$468.72M
−$429.13M
'25 Q4
26-02-24
▲2.6%
$496.25M
−$26.63M
'26 Q1
26-05-07
LATEST
▲46.9%
$652.52M
−$28.36M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Evolent Health, Inc. Q2 FY2026 Earnings Call
Revenue
$652.52M
▲ 46.9% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Evolent Health, Inc. Q1 FY2026 Earnings Call
Positive tone
Performance Suite and new client launches
Oncology and medical cost trend
Financial guidance and outlook
Revenue
$496.25M
▲ 2.6% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Evolent Health, Inc. Q4 FY2025 Earnings Call
Positive tone
Performance Suite contract migration
2026 revenue and EBITDA guidance
New partnerships and customer wins
Revenue
$468.72M
▼ 27.5% YoY Diluted EPS
$-3.84
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Evolent Health, Inc. Q3 FY2025 Earnings Call
Confident tone
Oncology market opportunity and pipeline
Performance Suite and enhanced protections
Margin expansion and adjusted EBITDA
Revenue
$479.53M
▼ 22.8% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Evolent Health, Inc. Q2 FY2025 Earnings Call
Positive tone
Oncology trend and Performance Suite
New partner wins and pipeline
2026 outlook
Revenue
$444.33M
▼ 31.3% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Evolent Health, Inc. Q1 FY2025 Earnings Call
Revenue
$483.65M
▼ 24.4% YoY Diluted EPS
$-0.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Evolent Health, Inc. Q4 FY2024 Earnings Call
Positive tone
Oncology cost trend and Performance Suite profitability
Organic growth and new contracts
2025 financial outlook and guidance
Revenue
$646.54M
▲ 16.3% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Evolent Health, Inc. Q3 FY2024 Earnings Call
Cautious tone
Reimbursement rate renegotiation
Specialty performance suite underwriting losses
2024 guidance reset / lowered EBITDA outlook
Revenue
$621.40M
▲ 21.6% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Evolent Health, Inc. Q2 FY2024 Earnings Call
Positive tone
2024 Adjusted EBITDA Guidance and $300M Exit Run Rate Target
New Revenue Agreements / Bookings
Rate Increases from Performance Suite Partners
Revenue
$647.14M
▲ 37.9% YoY Diluted EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Evolent Health, Inc. Q1 FY2024 Earnings Call
Positive tone
Revenue growth and guidance raise
Profitability and EBITDA expansion
Utilization and risk business pressures
Revenue
$639.65M
▲ 49.6% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Evolent Health, Inc. Q4 FY2023 Earnings Call
Confident tone
Financial Results and 2024 Outlook
Specialty Care / Performance Suite Expansion
Oncology and Technology and Services Suite
Revenue
$556.05M
▲ 45.4% YoY Diluted EPS
$-0.36
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Evolent Health, Inc. Q3 FY2023 Earnings Call
Revenue
$511.01M
▲ 44.9% YoY Diluted EPS
$-0.30
▼ 1600% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Evolent Health, Inc. Q2 FY2023 Earnings Call
Revenue
$469.14M
▲ 46.6% YoY Diluted EPS
$-0.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Evolent Health, Inc. Q1 FY2023 Earnings Call
Revenue
$427.69M
▲ 44% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Evolent Health, Inc. Q4 FY2022 Earnings Call
Revenue
$382.43M
▲ 54% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Evolent Health, Inc. Q3 FY2022 Earnings Call
Revenue
$352.58M
▲ 58.5% YoY Diluted EPS
$0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Evolent Health, Inc. Q2 FY2022 Earnings Call
Revenue
$319.94M
▲ 44.1% YoY Diluted EPS
$-0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Evolent Health, Inc. Q1 FY2022 Earnings Call
Revenue
$297.06M
▲ 38.1% YoY Diluted EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
Evolent Health, Inc. Q4 FY2021 Earnings Call
Revenue
$248.36M
▲ 0.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Evolent Health, Inc. Q3 FY2021 Earnings Call
Revenue
$222.47M
▼ 7.1% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Evolent Health, Inc. Q2 FY2021 Earnings Call
Revenue
$222.06M
▲ 2.2% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Evolent Health, Inc. Q1 FY2021 Earnings Call
Revenue
$215.07M
▼ 2.8% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Evolent Health, Inc. Q4 FY2020 Earnings Call
Revenue
$246.54M
▲ 4.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Evolent Health, Inc. Q3 FY2020 Earnings Call
Revenue
$239.57M
▲ 8.8% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-17
Evolent Health, Inc. Q2 FY2020 Earnings Call
Revenue
$217.30M
▲ 13.2% YoY Diluted EPS
$-2.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Evolent Health, Inc. Q1 FY2020 Earnings Call
Revenue
$221.23M
▲ 11.9% YoY Diluted EPS
$-0.93
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Evolent Health, Inc. Q4 FY2019 Earnings Call
Revenue
$236.53M
▲ 22.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1628908
CUSIP
30050B101
13F (30d)
185 filings
183 filers
Visit website
Investor relations